scispace - formally typeset
J

Jeremy Rowlette

Publications -  16
Citations -  257

Jeremy Rowlette is an academic researcher. The author has contributed to research in topics: Laser & Quantum cascade laser. The author has an hindex of 6, co-authored 16 publications receiving 201 citations.

Papers
More filters
Journal ArticleDOI

Large scale infrared imaging of tissue micro arrays (TMAs) using a tunable Quantum Cascade Laser (QCL) based microscope

TL;DR: It is demonstrated how a protein chemical image of the amide I band of a 2 × 2.4 cm(2) breast tissue microarray containing over 200 cores can be measured in 9 min, indicating that applications requiring chemical images from a few key wavelengths would be ideally served by laser-based microscopes.
Journal ArticleDOI

Mid-infrared metabolic imaging with vibrational probes.

TL;DR: Small vibrational tags were introduced as metabolic probes for mid-infrared imaging by coupling the emerging high-information-throughput MIR microscopy with specifically designed IR-active vibrational probes to interrogate various metabolic activities in cells, small organisms and mice.
Journal ArticleDOI

Introducing Discrete Frequency Infrared Technology for High-Throughput Biofluid Screening.

TL;DR: This reproducible methodology is used to show proof of concept rapid diagnostics; 40 unique dried liquid biopsies from brain, breast, lung and skin cancer patients were classified in 2.4 cumulative seconds against 10 non-cancer controls with accuracies of up to 90%.
Journal ArticleDOI

Utilizing broad gain bandwidth in quantum cascade devices

TL;DR: In this article, the performance of homo- geneous and heterogeneous quantum cascade gain media is explored in an external cavity configuration and the utilization of the broad gain bandwidth available from quantum cascade (QC) devices is considered.

Quantum cascade laser-based mid-infrared spectrochemical imaging of tissue and biofluids

TL;DR: Mid-infrared spectroscopic imaging has the distinct potential to improve cancer patient outcome through the identification of earlier stages of disease, drug resistance, new disease states and high-risk populations.